Tourette's Syndrome
Article Sidebar
Main Article Content
Abstract
Objective: To analyze the characteristics of Tourette's Syndrome (TS). Bibliographic review: TS is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by the presence of motor and phonic tics before 18 years of age and persisting for a period longer than 12 months without a secondary cause. It is more common in men than in women (3:1), with a reported prevalence ranging from 0.3 to 1% in the general population. Motor tics are sudden, rapid, recurrent, non-rhythmic, stereotyped motor movements, usually preceded by an impulse. Vocal tics include any tic that produces noise: sniffing, grunting, humming, clicking, screaming words over and over again. Final considerations: TS is a neurodevelopmental disorder in which patients present tics for a period longer than one year, being a condition associated with several comorbidities such as attention deficit hyperactivity disorder, obsessive-compulsive disorder, anxiety disorder, or oppositional defiant disorder. In this context, it is a disease that directly affects the patient's quality of life. Its treatment, first, with education about the disease and its clinical course, in addition to psychotherapy and drugs such as haloperidol, pimozide and aripiprazole.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. BILLNITZER A, JANKOVIC J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics, 2020; 17(4): 1681-1693.
3. CAVANNA AE. Current and emerging pharmacotherapeutic strategies for Tourette syndrome. Expert Opin Pharmacother, 2022; 23(13): 1523-1533.
4. EAPEN V, USHERWOOD T. Tourette syndrome in children. Aust J Gen Pract, 2021; 50(3): 120-125.
5. FREY J, MALATY IA. Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. Curr Neurol Neurosci Rep, 2022; 22(2): 123-142.
6. HARTMANN A, et al. Is Tourette syndrome a rare condition? F1000Res, 2021; 10: 434.
7. HSU CJ, et al. Immunological Dysfunction in Tourette Syndrome and Related Disorders. Int J Mol Sci, 2021; 22(2): 853.
8. LEE MY. Living with tics: Nursing care of pediatric tourette syndrome. Biomed J, 2022; 45(2): 280-285.
9. LIN WD, et al. Current understanding of the genetics of tourette syndrome. Biomed J, 2022; 45(2): 271-279.
10. MALEK A. Pain in Tourette Syndrome-Children's and Parents' Perspectives. J Clin Med, 2022; 11(2): 460.
11. MITTAL SO. Tics and Tourette's syndrome. Drugs Context, 2020; 9: 2019-12.
12. MIELKE E, et al. Tourette syndrome as a motor disorder revisited - Evidence from action coding. Neuroimage Clin, 2021; 30: 102611.
13. MULLER-VAHL K. Case in Context: Tourette Syndrome. Cannabis Cannabinoid Res, 2021; 6(2): 88-91.
14. NOMURA Y. Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do. Biomed J, 2022; 45(2): 229-239.
15. NOVOTNY M, et al. Tourette Syndrome: A Mini-Review. Front Neurol, 2018; 9: 139.
16. PRINGSHEIM T, et al. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 2019; 92(19): 907-915.
17. QUEZADA J, COFFMAN KA. Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome. CNS Drugs, 2018; 32(1): 33-45.
18. RAMTEKE A, LAMTURE Y. Tics and Tourette Syndrome: A Literature Review of Etiological, Clinical, and Pathophysiological Aspects. Cureus, 2022; 14(8): e28575.
19. SEIDEMAN MF, SEIDEMAN TA. A Review of the Current Treatment of Tourette Syndrome. J Pediatr Pharmacol Ther, 2020; 25(5): 401-412.
20. SZEJKO N, et al. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome. Neurol Neurochir Pol, 2022; 56(1): 28-38.
21. UEDA K, BLACK KJ. Recent progress on Tourette syndrome. Fac Rev, 2021; 10: 70.
22. YU D, et al. ppola G, Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. Am J Psychiatry, 2019; 176(3): 217-227.